Gheuens Sarah bought AGIO
November 11, 2025 · Form 4 insider transaction
Gheuens Sarah bought 2,454 shares of Agios Pharmaceuticals, Inc. at $25.01 per share, a transaction worth $61.4K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,454
Price
$25.01
Total value
$61.4K
InsiderGheuens Sarah
Role—
SecurityCommon stock
Transaction codeM: Option exercise
Transaction dateNovember 11, 2025
Filing dateNovember 13, 2025
Shares owned after64,181
OwnershipDirect
10b5-1 planNo
AmendedNo